TABLE 2.
Interview Participant Demographics
| Variable | n (%) |
|---|---|
| Mean age (SD), y | 40.5 (10.0) |
|
| |
| Sex | |
| Male | 16 (29) |
| Female | 40 (71) |
|
| |
| Ethnicity | |
| Hispanic and/or Latinx | 1 (2) |
| Non-Hispanic and/or non-Latinx | 55 (98) |
| Prefer not to disclose | 0 (0) |
|
| |
| Race | |
| American Indian or Alaska Native | 0 (0) |
| Asian | 4 (7) |
| Black or African American | 1 (2) |
| Native Hawaiian or Pacific Islander | 0 (0) |
| White | 46 (82) |
| Multiple races | 3 (5) |
| Other | 1 (2) |
| Prefer not to disclose | 1 (2) |
|
| |
| Primary rolea | |
| Administrator | 8 (14) |
| Physician | 15 (27) |
| Nurse | 12 (21) |
| Respiratory therapist | 9 (16) |
| Site PI | 12 (21) |
|
| |
| Site typeb | |
| Low cSpO2 use | 28 (50) |
| High cSpO2 use | 29 (50) |
a
Some participants had multiple roles (eg, Site PIs were also typically attending physicians).
b
“Low cSpO2 use” site denotes fewer than 25% of stable bronchiolitis patients were monitored with cSpO2 during observations conducted in a previous study; “High cSpO2 use” site denotes more than 25% of stable bronchiolitis patients were monitored. Among the 6 hospitals categorized as low overuse, the median percent monitored was 12% (IQR 5%-21%, range 1%-25%). Among the 6 hospitals categorized as high overuse, the median percent monitored was 79%, IQR 78%-81%, range 76%-92%.